Projects actively funded in 2011–2012
Biomonitoring 2.0: A high-throughput genomics approach to comprehensive biological assessment of environmental change
→ Mehrdad Hajibabaei
University of Guelph
July 2011 – June 2014
$3.1 Million
NorCOMM2 – In vivo models for human disease & drug discovery
→ Colin McKerlie
Mount Sinai Hospital, Toronto
→ Steve Brown
Medical Research Council Harwell (UK)
July 2011 – June 2014
$10.9 Million
Synthetic antibody program: commercial reagents and novel therapeutics
→ Sachdev Sidhu, Charles Boone
University of Toronto
July 2011 – June 2014
$9.9 Million
Therapeutic Opportunities to Target Tumor Initiating Cells in Solid Tumors
→ Tak Mak
University Health Network, Toronto
June 2010 – May 2014
$40.0 million
Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)
→ John Dick, Jean Wang
University Health Network, Toronto
April 2010 – March 2014
$31.8 million
Genomics for Crop Improvement: Agricultural Pest Management
→ Miodrag Grbic
University of Western Ontario, London
October 2009 – September 2013
$6.3 million
Bioproducts and Enzymes from Environmental Metagenomes (BEEM)
→ Elizabeth Edwards
University of Toronto
→ David Major
Geosyntec Consultants, Guelph
October 2009 – September 2013
$11.0 million
Finding of Rare Disease Genes in Canada (FORGE Canada)
→ Kym Boycott
Children’s Hospital of Eastern Ontario Research Institute, Ottawa
April 2011 – March 2013
$4.1 Million
The Centre for Applied Genomics (TCAG)
Science & Technology Innovation Centre
→ Stephen Scherer
Hospital for Sick Children, Toronto
January 2006 – March 2013
$14.4 million
International Barcode of Life (iBOL)
→ Paul Hebert
University of Guelph
July 2008 – December 2012
$19.8 million
Structural Genomics Consortium (SGC) – Phase III
→ Aled Edwards
University of Toronto
University of Oxford (UK)
July 2011 – June 2012
$16.2 million
Structural Genomics Consortium (SGC) – Phase II
→ Aled Edwards
University of Toronto
University of Oxford (UK)
Karolinska Institute, Stockholm (Sweden)
July 2007 – June 2011
$118.5 million
Structural and Functional Annotation of the Human Genome for Disease Study
→ Robert Hegele
Robarts Research Institute, London
October 2006 – June 2011
$21.6 million
Dollar amounts are total approved project costs as of March 31, 2012